UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash flows from operating activities:
Net (loss) income including noncontrolling interests in subsidiaries	$ (17,601)	$ 23,528
Adjustments to reconcile net (loss) income including noncontrolling interests in subsidiaries to net cash provided by operating activities:
Depreciation, depletion and amortization	8,487	10,610
Accretion of asset retirement obligation	455	434
Gain on disposal of assets	(487)	0
Compensation expense for share-based awards	1,000	922
Loss (gain) on foreign currency exchange	59	(155)
Change in fair value of equity securities	1,559	4,777
Loss (gain) on sale of equity securities	605	(1,605)
Unrealized loss on derivatives	9,726	4,978
Deferred income taxes	(3,424)	3,323
Changes in operating assets and liabilities:
Accounts receivable	(2,537)	(68,814)
Inventories	3,143	1,220
Prepaid expenses and other assets	8,620	728
Accounts payable and accrued expenses	(6,211)	1,223
Royalties and contingent legal fees payable	(131)	21,249
Deferred revenue	140	7
Net cash provided by operating activities	3,403	2,425
Cash flows from investing activities:
Acquisition, net of cash acquired and working capital adjustments	0	1,230
Patent acquisition	(1,750)	0
Purchases of equity securities	0	(4,827)
Sales of equity securities	1,181	6,726
Proceeds from loans receivable	7,200	0
Purchases of property and equipment	(740)	0
Net additions to oil and gas properties	(8,454)	(2,090)
Proceeds from disposition of property and equipment	1,581	0
Net cash (used in) provided by investing activities	(982)	1,039
Cash flows from financing activities:
Paydown of Benchmark revolving credit facility	0	(5,000)
Paydown of Deflecto Facility	1,581	600
Taxes paid related to net share settlement of share-based awards	(320)	(471)
Net cash used in financing activities	(1,901)	(6,071)
Effect of exchange rates on cash and cash equivalents	268	691
Increase (decrease) in cash and cash equivalents	788	(1,916)
Cash and cash equivalents, beginning of period	306,719	273,880
Cash and cash equivalents, end of period	$ 307,507	$ 271,964